Wachovia downgrades Symmetry Medical (NYSE: SMA) from Outperform to Market Perform with a $19-$21 valuation range.

The firm said ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE